Quest Diagnostics Incorporated (DGX)

Quest Diagnostics, Inc.'s liquidity ratios reflect how well the company can meet its short-term obligations. The current ratio has decreased over the past five years, from 1.25 in 2019 to 1.31 in 2023. This ratio indicates the company's ability to cover its current liabilities with its current assets, and a current ratio above 1 indicates a healthy level of liquidity. However, the downward trend may suggest a slight deterioration in short-term liquidity.

The quick ratio, which provides a more stringent measure of liquidity by excluding inventory from current assets, also shows a decreasing trend for Quest Diagnostics. It decreased from 1.19 in 2019 to 1.20 in 2023. This indicates that the company may have a lower ability to meet its short-term liabilities without relying on inventory sales.

The cash ratio, which is the most conservative measure of liquidity, has fluctuated over the five-year period. It ranged from 0.33 in 2022 to 0.74 in 2020. The decrease in the cash ratio to 0.54 in 2023 may indicate that Quest Diagnostics has a lower proportion of cash to cover its current liabilities, which could pose some concern regarding its immediate liquidity position.

Overall, while Quest Diagnostics, Inc. maintains liquidity levels above 1 in its current, quick, and cash ratios, the declining trend in these ratios suggests a potential weakening in the company's short-term financial position over the past five years. This analysis indicates that the company may need to closely monitor its liquidity management to ensure it can meet its short-term obligations efficiently.

---

Additional liquidity measure

The cash conversion cycle of Quest Diagnostics, Inc. has shown a declining trend over the past five years, indicating improved efficiency in managing its cash flows related to operations. In 2023, the company's cash conversion cycle stood at 36.67 days, slightly higher than the previous year's 36.66 days.

The cash conversion cycle measures the time taken for a company to convert its investments in inventory and other resources into cash inflows from sales. A shorter cash conversion cycle is generally favorable as it signifies that the company is able to generate cash quickly from its operating activities.

Quest Diagnostics has been successful in consistently reducing its cash conversion cycle over the years, showcasing effective management of its working capital and operational efficiency. This trend suggests that the company has been more efficient in managing its inventory, accounts receivable, and accounts payable, leading to quicker cash turnover.

Overall, the decreasing trend in Quest Diagnostics' cash conversion cycle reflects improved financial health and operational effectiveness, signaling positive signals for the company's liquidity and cash flow management.